BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 104 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,094,000 | +82.6% | 352,888 | +112.5% | 0.00% | – |
| Q3 2021 | $599,000 | +27.4% | 166,052 | +26.2% | 0.00% | – |
| Q2 2021 | $470,000 | -37.9% | 131,596 | -32.1% | 0.00% | – |
| Q1 2021 | $757,000 | +8.0% | 193,797 | +16.2% | 0.00% | – |
| Q4 2020 | $701,000 | +915.9% | 166,741 | +807.8% | 0.00% | – |
| Q3 2020 | $69,000 | -92.6% | 18,367 | -91.5% | 0.00% | -100.0% |
| Q2 2020 | $937,000 | +31133.3% | 214,950 | +23188.2% | 0.00% | – |
| Q1 2020 | $3,000 | +50.0% | 923 | +230.8% | 0.00% | – |
| Q4 2019 | $2,000 | -98.8% | 279 | -99.3% | 0.00% | – |
| Q3 2019 | $173,000 | -35.9% | 41,254 | -29.1% | 0.00% | – |
| Q2 2019 | $270,000 | -80.9% | 58,150 | -78.2% | 0.00% | -100.0% |
| Q1 2019 | $1,415,000 | +16.6% | 266,919 | -18.6% | 0.00% | 0.0% |
| Q4 2018 | $1,214,000 | +1279.5% | 328,039 | +942.8% | 0.00% | – |
| Q3 2018 | $88,000 | -5.4% | 31,457 | 0.0% | 0.00% | – |
| Q2 2018 | $93,000 | -21.2% | 31,457 | -39.9% | 0.00% | – |
| Q1 2018 | $118,000 | -44.6% | 52,369 | -27.7% | 0.00% | – |
| Q4 2017 | $213,000 | – | 72,386 | +126893.0% | 0.00% | – |
| Q3 2017 | $0 | – | 57 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 57 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 57 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 57 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 57 | -99.0% | 0.00% | – |
| Q2 2016 | $13,000 | -51.9% | 5,733 | -37.4% | 0.00% | – |
| Q1 2016 | $27,000 | -93.3% | 9,157 | -90.9% | 0.00% | – |
| Q4 2015 | $402,000 | -18.0% | 100,546 | +2.7% | 0.00% | -100.0% |
| Q3 2015 | $490,000 | +988.9% | 97,941 | +1414.5% | 0.00% | – |
| Q2 2015 | $45,000 | +275.0% | 6,467 | +414.9% | 0.00% | – |
| Q1 2015 | $12,000 | -82.9% | 1,256 | -78.5% | 0.00% | – |
| Q4 2014 | $70,000 | -90.1% | 5,836 | -86.0% | 0.00% | -100.0% |
| Q3 2014 | $708,000 | +7766.7% | 41,676 | +5270.6% | 0.00% | – |
| Q2 2014 | $9,000 | -25.0% | 776 | -49.4% | 0.00% | – |
| Q1 2014 | $12,000 | +300.0% | 1,535 | +131.5% | 0.00% | – |
| Q4 2013 | $3,000 | -50.0% | 663 | -40.9% | 0.00% | – |
| Q3 2013 | $6,000 | -83.8% | 1,122 | -87.6% | 0.00% | – |
| Q2 2013 | $37,000 | – | 9,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invenomic Capital Management LP | 1,188,759 | $3,685,000 | 0.79% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 4,339,837 | $13,453,000 | 0.40% |
| EMC Capital Management | 208,733 | $647,000 | 0.35% |
| Rubric Capital Management LP | 1,747,401 | $5,417,000 | 0.26% |
| Zebra Capital Management LLC | 50,887 | $158,000 | 0.25% |
| Hillsdale Investment Management Inc. | 1,184,300 | $3,672,000 | 0.25% |
| WEALTH EFFECTS LLC | 100,300 | $311,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 114,000 | $353,000 | 0.13% |
| Manteio Capital LLC | 23,879 | $74,000 | 0.10% |
| GLOBEFLEX CAPITAL L P | 273,162 | $846,000 | 0.09% |